Conestoga Capital Advisors, LLC Pfizer Inc Transaction History

Conestoga Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $163,373 - $202,439	-3,571 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $147,553 - $218,723	3,571 New	3,571 $211,000
Q1 2021 Apr 23, 2021	SELL	$33.49 - $37.77 $606,436 - $683,939	-18,108 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $20,082 - $25,536	600 Added 3.43%	18,108 $667,000
Q3 2020 Oct 23, 2020	BUY	$31.75 - $37.25 $12,700 - $14,900	400 Added 2.34%	17,508 $643,000
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $39,508 - $45,044	-1,027 Reduced 5.66%	17,108 $747,000
Q1 2018 Apr 24, 2018	BUY	$31.91 - $37.02 $15,955 - $18,510	500 Added 2.84%	18,135 $644,000
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $546,685 - $602,235	17,635	17,635 $630,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.